The low density lipoprotein receptor-related protein modulates protease activity in the brain by mediating the cellular internalization of both neuroserpin and neuroserpin-tissue-type plasminogen activator complexes

被引:57
作者
Makarova, A
Mikhailenko, I
Bugge, TH
List, K
Lawrence, DA
Strickland, DK
机构
[1] Amer Red Cross, Jerome H Holland Lab, Dept Vasc Biol, Rockville, MD 20855 USA
[2] George Washington Univ, Med Ctr, Inst Biomed Sci, Washington, DC 20037 USA
[3] NIDCR, Proteases & Tissue Remodeling Unit, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.M309150200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteases contribute to a variety of processes in the brain; consequently, their activity is carefully regulated by protease inhibitors, such as neuroserpin. This inhibitor is thought to be secreted by axons at synaptic regions where it controls tissue-type plasminogen activator (tPA) activity. Mechanisms regulating neuroserpin are not known, and the current studies were undertaken to define the cellular pathways involved in neuroserpin catabolism. We found that both active neuroserpin and neuroserpin . tPA complexes were internalized by mouse cortical cultures and embryonic fibroblasts in a process mediated by the low density lipoprotein receptor-related protein (LRP). Surprisingly, despite the fact that active neuroserpin is internalized by LRP, this form of the molecule does not directly bind to LRP on its own, indicating the requirement of a cofactor for neuroserpin internalization. Our studies ruled out the possibility that endogenously produced plasminogen activators (i.e. tPA and urokinase-type plasminogen activator) are responsible for the LRP-mediated internalization of active neuroserpin, but could not rule out the possibility that another cell-associated proteases capable of binding active neuroserpin functions in this capacity. In summary, neuroserpin levels appear to be carefully regulated by LRP and an unidentified cofactor, and this pathway may be critical for maintaining the balance between proteases and inhibitors.
引用
收藏
页码:50250 / 50258
页数:9
相关论文
共 48 条
[1]   The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor [J].
Argraves, KM ;
Kozarsky, KF ;
Fallon, JT ;
Harpel, PC ;
Strickland, DK .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2170-2181
[2]   THE HUMAN ALPHA-2-MACROGLOBULIN RECEPTOR - IDENTIFICATION OF A 420-KD CELL-SURFACE GLYCOPROTEIN SPECIFIC FOR THE ACTIVATED CONFORMATION OF ALPHA-2-MACROGLOBULIN [J].
ASHCOM, JD ;
TILLER, SE ;
DICKERSON, K ;
CRAVENS, JL ;
ARGRAVES, WS ;
STRICKLAND, DK .
JOURNAL OF CELL BIOLOGY, 1990, 110 (04) :1041-1048
[3]   The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-D-aspartate receptors [J].
Bacskai, BJ ;
Xia, MQ ;
Strickland, DK ;
Rebeck, GW ;
Hyman, BT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (21) :11551-11556
[4]   Acyl-enzyme complexes between tissue-type plasminogen activator and neuroserpin are short-lived in vitro [J].
Barker-Carlson, K ;
Lawrence, DA ;
Schwartz, BS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (49) :46852-46857
[5]  
BATTEY FD, 1994, J BIOL CHEM, V269, P23268
[6]   Mutant neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro [J].
Belorgey, D ;
Crowther, DC ;
Mahadeva, R ;
Lomas, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (19) :17367-17373
[7]   Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator [J].
Bugge, TH ;
Flick, MJ ;
Danton, MJS ;
Daugherty, CC ;
Romer, J ;
Dano, K ;
Carmeliet, P ;
Collen, D ;
Degen, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :5899-5904
[8]   Reelin is a ligand for lipoprotein receptors [J].
D'Arcangelo, G ;
Homayouni, R ;
Keshvara, L ;
Rice, DS ;
Sheldon, M ;
Curran, T .
NEURON, 1999, 24 (02) :471-479
[9]   Familiar encephalopathy with neuroserpin inclusion bodies [J].
Davis, RL ;
Holohan, PD ;
Shrimpton, AE ;
Tatum, AH ;
Daucher, J ;
Collins, GH ;
Todd, R ;
Bradshaw, C ;
Kent, P ;
Feiglin, D ;
Rosenbaum, A ;
Yerby, MS ;
Shaw, CM ;
Lacbawan, F ;
Lawrence, DA .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) :1901-1913
[10]   Familial dementia caused by polymlerization of mutant neurosergin [J].
Davis, RL ;
Shrimpton, AE ;
Holohan, PD ;
Bradshaw, C ;
Feiglin, D ;
Collins, GH ;
Sonderegger, P ;
Kinter, J ;
Becker, LM ;
Lacbawan, F ;
Krasnewich, D ;
Muenke, M ;
Lawrence, DA ;
Yerby, MS ;
Shaw, CM ;
Gooptu, B ;
Elliott, PR ;
Finch, JT ;
Carrell, RW ;
Lomas, DA .
NATURE, 1999, 401 (6751) :376-379